Cargando…

Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay

The multi-target effects of natural products allow us to fight complex diseases like cancer on multiple fronts. Unlike docking techniques, network-based approaches such as genome-scale metabolic modelling can capture multi-target effects. However, the incompleteness of natural product target informa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cipriani, Claudia, Pacheco, Maria Pires, Kishk, Ali, Wachich, Maryem, Abankwa, Daniel, Schaffner-Reckinger, Elisabeth, Sauter, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875459/ https://www.ncbi.nlm.nih.gov/pubmed/35215292 http://dx.doi.org/10.3390/ph15020179

Ejemplares similares

Bruceine A
por: Feng, Xue-Huan, et al.
Publicado: (2010)

DCcov: Repositioning of drugs and drug combinations for SARS-CoV-2 infected lung through constraint-based modeling
por: Kishk, Ali, et al.
Publicado: (2021)

Eliminating oncogenic RAS: back to the future at the drawing board
por: Steffen, Candy Laura, et al.
Publicado: (2023)

Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis
por: Dou, Yao-Xing, et al.
Publicado: (2018)

A brief overview of antitumoral actions of bruceine D
por: Sin, Zi Wayne, et al.
Publicado: (2020)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
por: Le, Brian L., et al.
Publicado: (2021)

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma
por: Bintener, Tamara, et al.
Publicado: (2023)

Identifying and targeting cancer-specific metabolism with network-based drug target prediction
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas
por: Tian, Saisai, et al.
Publicado: (2020)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease
por: Wu, Qihui, et al.
Publicado: (2023)

Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling
por: Wu, Jiahui, et al.
Publicado: (2022)

Alamar Blue assay optimization to minimize drug interference and inter-assay viability
por: Dinh, Mina N., et al.
Publicado: (2023)

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
por: Cummings, Jeffrey L, et al.
Publicado: (2014)

Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
por: Larsson, Peter, et al.
Publicado: (2020)

Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
por: Zhang, Juan, et al.
Publicado: (2022)

L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness
por: Machado, Raquel A. C., et al.
Publicado: (2021)

Towards the routine use of in silico screenings for drug discovery using metabolic modelling
por: Bintener, Tamara, et al.
Publicado: (2020)

Towards the network-based prediction of repurposed drugs using patient-specific metabolic models
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay
por: Linares, María, et al.
Publicado: (2015)

A multilevel screening pipeline in zebrafish identifies therapeutic drugs for GAN
por: Lescouzères, Léa, et al.
Publicado: (2023)

Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions
por: Lariosa-Willingham, Karen D., et al.
Publicado: (2016)

Development of a High-throughput Agar Colony Formation Assay to Identify Drug Candidates against Medulloblastoma
por: Sedeeq, Mohammed, et al.
Publicado: (2020)

Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening
por: Wu, Yifei, et al.
Publicado: (2023)

Deep Learning for Identifying Promising Drug Candidates in Drug–Phospholipid Complexes
por: Yoo, Soyoung, et al.
Publicado: (2023)

Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo
por: Fan, Jiangjiang, et al.
Publicado: (2020)

A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity
por: Lu, Cai, et al.
Publicado: (2021)

Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays
por: Cumming, Bridgette M., et al.
Publicado: (2021)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

119 The Anti-HIV Drug Pipeline
por: Bartlett, John G.
Publicado: (2014)

Alzheimer's drug-development pipeline: 2016
por: Cummings, Jeffrey, et al.
Publicado: (2016)

Bruceine D inhibits tumor growth and stem cell‐like traits of osteosarcoma through inhibition of STAT3 signaling pathway
por: Wang, Shangyu, et al.
Publicado: (2019)

The anti-migration and anti-invasion effects of Bruceine D in human triple-negative breast cancer MDA-MB-231 cells
por: Luo, Can, et al.
Publicado: (2020)

Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
por: Huang, Rui, et al.
Publicado: (2021)

Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway
por: Zhang, Chaozheng, et al.
Publicado: (2023)

A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells
por: Kleijn, A., et al.
Publicado: (2016)

An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval
por: Lorberbaum, Tal, et al.
Publicado: (2016)

A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma
por: Somarelli, Jason A., et al.
Publicado: (2020)

An in silico–in vitro pipeline for drug cardiotoxicity screening identifies ionic pro‐arrhythmia mechanisms
por: Clark, Alexander P., et al.
Publicado: (2022)

A flow-cytometry-based pipeline for the rapid quantification of C2C12 cell differentiation
por: Parisi, Bianca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bj6tr92lhha15dqbs02ps8enqk